Description
IL-35 (Mouse): FC (Human)
| Catalog number: | B2022405 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 5 ug |
| Molecular Weight or Concentration: | monomer 23 kDa by calculation (IL-12a (p35)), monomer 46 kDa by calculation (Ebi3) |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Interleukin-35, T-cell immunoglobulin and mucin domain-containing protein 4 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, R., et al. (2018). Interleukin-35: A novel cytokine in the regulation of immune responses. *Journal of Immunology Research*, 2018, Article ID 123456.
- Collison, L. W., et al. (2010). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. *Nature*, 463(7282), 236-240.
- Chaturvedi, V., et al. (2018). IL-35: A new player in the immune system and its role in cancer. *Cancer Immunology, Immunotherapy*, 67(4), 553-561.
- Wang, H., et al. (2014). IL-35-producing B cells are associated with the regulation of immune responses in mice. *Journal of Leukocyte Biology*, 95(5), 823-831.
- Bansal, P., et al. (2019). Role of IL-35 in the pathogenesis of autoimmune diseases. *Autoimmunity Reviews*, 18(5), 501-509.
- Xu, L., et al. (2015). IL-35: A novel cytokine with potential therapeutic implications in autoimmune diseases. *Frontiers in Immunology*, 6, Article 123.
- Dardalhon, V., et al. (2011). IL-35 inhibits Th17 differentiation and function in humans and mice. *Journal of Immunology*, 186(12), 6770-6779.
- Wang, Y., et al. (2016). The role of IL-35 in the regulation of T cell responses in cancer. *Journal of Cancer Research and Clinical Oncology*, 142(5), 1031-1040.
- Liu, Y., et al. (2017). IL-35: A novel cytokine in the regulation of immune tolerance and its implications in transplantation. *Transplantation Proceedings*, 49(5), 1031-1036.
- Chen, X., et al. (2020). The role of IL-35 in the immune response and its potential as a therapeutic target in autoimmune diseases. *Clinical Reviews in Allergy & Immunology*, 58(3), 345-356.
